Distinguishing the surface markers of cancer stem cells (CSCs) is a useful method for early diagnosis and treatment of tumors, as CSCs may participate in tumorigenesis and metastasis by migrating into the circulatory system. However, the potential targets of CSCs are expressed at low levels in the natural state and are always changing. Thus, dynamic screening has been reported to be an effective measure for exploring CSC markers. In recent years, diverse single-chain variable fragments (scFvs) have been widely used in immunotherapy. In this study, we determined that the scFvs, screened using RD, had a high affinity to microspheres and could inhibit their progression. We also observed that the selected scFvs underwent evolution in vitro, and antitumor-associated proteins were successfully expressed. Combined with chemotherapy, the scFvs had a synergistic effect on the inhibition of the microspheres' progression in vitro and in vivo, which could be ascribed to their high affinity for stem-like cells and the inhibition of the microspheres' collective behaviors. In addition, proteins inhibiting CD44 + /CD24 + and MAPK were involved. Our data indicated that dynamic screening of the scFvs in a natural state was of great significance in the inhibition of the microspheres in vitro and in vivo.
Distinguishing the surface markers of cancer stem cells (CSCs) is a useful method for early diagnosis and treatment of tumors, as CSCs may participate in tumorigenesis and metastasis by migrating into the circulatory system. However, the potential targets of CSCs are expressed at low levels in the natural state and are always changing. Thus, dynamic screening has been reported to be an effective measure for exploring CSC markers. In recent years, diverse single-chain variable fragments (scFvs) have been widely used in immunotherapy. In this study, we determined that the scFvs, screened using RD, had a high affinity to microspheres and could inhibit their progression. We also observed that the selected scFvs underwent evolution in vitro, and antitumor-associated proteins were successfully expressed. Combined with chemotherapy, the scFvs had a synergistic effect on the inhibition of the microspheres' progression in vitro and in vivo, which could be ascribed to their high affinity for stem-like cells and the inhibition of the microspheres' collective behaviors. In addition, proteins inhibiting CD44 + /CD24 + and MAPK were involved. Our data indicated that dynamic screening of the scFvs in a natural state was of great significance in the inhibition of the microspheres in vitro and in vivo. in tumor metastasis. 1 In recent years, researchers have observed that the morphology and surface markers of CSCs could change with the environment, 2, 3 and their behaviors were more collective than their parental cancer cells. 4 In addition, CSCs can result in cancer metastasis through circulatory system migration. 5, 6 Targeted treatment in combination with chemotherapy has played an important active role in drugresistant and metastatic cancer. However, the impact on CSCs still remains unclear. 7 Due to the small number of CSCs and the low expression of stem cell-associated markers in the natural state of solid tumors, 8, 9 we have reasons to believe that a high-flux, sensitive, and efficient system for screening specific molecules of CSCs will be a significant method in the early diagnosis, prediction, and targeted therapy of CSCs. In this study, we used RD to screen scFvs, as they have a high affinity for antigens and are convenient for molecular modification in vitro. 10 Because of the diversity of scFv libraries, many antibodies and antigens have been selected and investigated in previous research.
11 ,12 Antibody library display technology has been widely used by researchers of pharmacy and medical science. 11 The most important factor is to screen for antibodies with high affinity and specificity. In particular, RD is one of the most powerful in vitro display technologies used to screen for single chain antibodies. 13 During the translation process of RD, PRM are formed. Following the PRM screening, the binding ligands of mRNA are enriched, and new mRNA can be amplified by RT-PCR. Next, new PRM can be formed and entered for the next round of screening. The sequence of the gene and the polypeptide can then be detected and separated. After repeating this several times, the molecules with a high specificity and affinity can be obtained. 10, 11 As RDs can be modified or marked with incorporation of non-natural amino acids in protein synthesis, the technology is also an effective method to study protein evolution. 14, 15 The affinity recognition of multiple targets is an important treatment method for solid tumors based on our understanding of gene technology and CSC markers. 16, 17 As we know, the CD44 + CD24
À/low lineage of breast cancer cells has been thought to be breast CSCs. 18 However, CD24 + cells are considered more closely related to the early, highly invasive, and differentiated cells in mammary tumors. 17, 19 We infer that CSCs themselves may always be in a dynamic balance and inhomogeneous collective state. As Reya et al 20 have suggested, cancer cells, stem cells, and CSCs may share a common signaling pathway. We suppose the best maker selection and treatment may be given consideration to the stemness and differentiation of CSCs. Based on several early research reports and our preliminary study analysis, we speculate that the CD44 + /CD24 + and MAPK pathways could play a shared role in proliferation and differentiation in cancer cells and CSCs. [21] [22] [23] In this study, a large-scale screening of clinically functional scFvs was explored.
An RD was applied to screen for high-affinity and evolved scFvs with stem-like microspheres. Our data suggest that the screened scFvs alone or in combination with chemotherapy could effectively inhibit tumor proliferation and invasion in vitro and in vivo.
| MATERIALS AND METHODS

| Cell lines and culture
Details are provided in Document S1.
| Enrichment and sequencing of stem-like cells
| Cell surface markers analysis
| Xenograft tumor growth in athymic nude mice
| Establishment of solid phase cell membrane screening
| Patient specimens
Forty-five blood samples of breast cancer patients and 10 blood samples of breast adenoma or hyperplasia patients were acquired (Table S1 ). Details are provided in Document S1 and Table S4 .
| In vitro transcription and translation
| Affinity selection and RT-PCR
| Analysis of the translation proteins
| MTT assay
| Assessment of apoptosis
| Enzyme-linked immunosorbent assay
| Immunofluorescence assay
| Cell migration and invasion assays
| Immunohistochemical staining and evaluation
| Western blot analysis
| Statistical analysis
3 | RESULTS
| Anti-breast cancer scFvs and RD libraries were constructed
Total RNA was isolated from peripheral blood lymphocytes from blood samples of breast cancer patients ( Figure 1A , Table S1 ). Single bands of the correct size of VH (approximately 340 bp) ( Figure 1B , Table S2) and VL ( Table S1 ), as well as a higher proportion of Leu/Lym (P = .0418; Table S1 ). However, there was no significant association between Leu/Lym and tumor stage or receptor state in this population.
Next, the gene III fragment was amplified from the bacteriophage M13 genomic DNA (Figures 2A,B and S1). Two other overlap extension PCRs were used to introduce the 5 0 -stem loop, T7 promoter, ribosome binding site (Table S3) (Table S4) were all significantly prognostic in the microspheres ( Figure 3C ).
Next, the active surfaces of these stem-like cell membranes were projected onto the fixed platform, and they showed various forms, such as sheets, spheres, and single cell shapes ( Figure 3D ). After screening, the cells shrank while the surface of the cell membranes preserved their morphological integrity in general ( Figure 3E ). Following multiple high-affinity screening, these cell clusters revealed a clear collective inhibition state ( Figure 3E ). All of these results indicate that the affinity screening platform contained collective microsphere cells with their differentiated and following cells. The screened cell membranes are intact and effective, showing a high affinity; thus, multiple screenings can lead to microspheres' collective inhibition.
3.3 | High-affinity scFvs were selected and translation proteins with antitumor features were identified
The mRNAs of scFvs were isolated successfully from the ribosomal complexes. Next, the purified mRNA was reversed to cDNA, and the cDNA was recovered with the identification primers for the new scFv library ( Figure 4A ). This new scFv library could be amplified with the non-corresponding primers and corresponding primers (Table S3) .
Next Figure 4B , Table S3 ). After at least three rounds of screening, we obtained a relatively stable scFv library ( Figure 4C, scFv 3) . Using sequencing and blasting in NCBI BLASTX, the 5 0 -end contained the specific hits of IGv, and the 3 0 -end was in line with the non-specific hits of IG-L-j ( Figure S2 ). By in vitro translation, the results showed that the scFv proteins were expressed from the ribosome complex, as
shown by the fluorescent SDS-PAGE staining on the gel ( Figure 4D ).
However, the signals showed that the target ribosome complex proteins were expressed weakly in the first screening, which was located between 25 and 35 kDa ( Figure 4D,E) . Interestingly, certain highmolecular-weight proteins were also translated ( Figure 4E ). With multiple selections, the expression of the target scFv proteins were clearly enhanced ( Figure 4F ). The translation proteins had antitumor activities, as they were in similar positions to the serum-isolated proteins from the breast cancer patients ( Figure 4D-F) . Taken together, all of the above results indicate that through the repeated cyclic affinity screening, carrying the active and high-affinity of anti-breast cancer, scFvs obtained molecular evolution in vitro.
| Single-chain variable fragments had high affinity with microspheres to inhibit their proliferation
To further clarify the properties of these scFv libraries, we synthesized and validated their effects on microspheres in vitro. After the F I G U R E 3 Screening platform of the cell membrane phase was built and applied. A, Microsphere cells were observed by light microscopy: shape at 2 weeks (9400); differentiation (9400); collective activity (9200); and crystal violet solution staining (9200) shown in panels left to right, respectively. B, Expression profiles of CD44 and CD24 in MDA-MB-231 cells and microspheres. Data are expressed as mean AE SD and compared by Student's t-test. PE, phycoerythrin. C, Stemness genes were tested by real-time PCR. Normalized gene expression was compared to normal breast cells for standardization. Data are expressed as the mean AE SD and compared by Student's t-test. D, Screening platform of living fixed stem-like microspheres and differentiated cells (9200). E, After peptide-ribosome-mRNA (PRM) screening, the fixed stem-like cells and membranes (9400) and crystal violet staining (9400); the collective activity of microspheres was inhibited after multiple screening and staining by crystal violet solution (9200). *P < .05; **P < .01; ***P < .001 selected scFvs were added ( Figure S2, scFv 3) , the proliferation rate of MDA-MB-231 and its microspheres were significantly inhibited, especially over 24 hours and at 100 nmol/L concentration ( Figure 5A ). This inhibitory effect was clearly enhanced if ≥4 lg/mL epirubicin was added ( Figure 5A ). Interestingly, this inhibitory effect was weak for HBL-100 ( Figure 5A ), and it did not show significant inhibition and toxicity to 293T and HL-7702 cells ( Figure S3A ). Furthermore, in morphology, the formation, growth, and collective structure of the microspheres were all significantly inhibited ( Figure 5B ). Through apoptosis detection, the results
showed that both the HBL-100 and microspheres did not show a significant apoptosis rate in response to the scFvs. In contrast, the combination therapy significantly increased the microspheres' apoptosis rate, although it was a low concentration of chemotherapeutic agents ( Figure 5C ).
To test whether the effects on proliferation and apoptosis were related to the antigen and antibody affinity, three 100 nmol/L single scFv incubated for 12 hours were detected with CD44, ALDH1, and CA-153 antigens by ELISA. The data showed that the last selection and synthesis of scFv 3 showed high affinity to all three antigens ( Figure 5D ). Furthermore, the luminescence of CD44 and CD24 was clearly decreased and weakened by immunofluorescence when 100 nmol/L scFv was added to the microspheres and incubated for 12 hours ( Figure 5E ). This influence was not significantly observed in the HBL-100 group ( Figure S3B ). At the same time, Western blot analysis showed that the expression of CD44 and CD24 was significantly decreased ( Figure 5F ). All of these results indicate that the scFvs have high affinity with microspheres to inhibit their proliferation, and they have no significant toxicity to HBL-100, 293T, or HL-7702 cells. When combined with chemotherapy, their apoptosis effect on microspheres can be notably enhanced.
| Combination of scFvs and chemotherapy inhibited microsphere invasion and progression
Non-trypsinized treated microspheres and their following intervention groups were tested on Transwell assays ( Figure 6A ). Quantitative analysis indicated that the numbers of migrating and invading cells in each intervention group were all significantly decreased relative to the microspheres control group ( Figure 6A ). Interestingly, the scFvs inhibited the microspheres' collective structures and behaviors ( Figure 6A ). In the in vivo study, after the adjacent tumor was subjected to the combination treatment, the growth and volume of tumors were significantly inhibited, and the cumulative treatment could achieve a long stable disease effect ( Figure 6B ). Liver metastasis (1/5) was only observed in the PBS control group ( Figure 6C ). There was no significant change in liver, heart, lung, or spleen morphologies in the control and combination treatment groups ( Figure 6C ). In particular, there was no obvious toxic reaction by the liver, lung, or spleen in the two groups (Figure 6D) . The results of immunohistochemistry showed that the expression of PCNA, MMP9, and CD44 were all significantly inhibited in the combination treatment group ( Figure 6E ).
By further Western blot analysis, both CD44 and CD24 were observed to be expressed at significantly lower levels after the combination treatment ( Figure 6F ). As we observed that the ERK, p38, and JNK genes are all located in the convergence point of the MAPK pathway, which is closely related to the proliferation and differentiation of stem-like cells ( Figure S4 ), we further detected the expression of these three proteins. The results
showed that the proteins were all significantly decreased after the combination treatment ( Figure 6G ). Taken together, these findings indicate that the proteins related with stemness, growth, and differentiation pathways can be significantly inhibited in vivo by combination treatment. All of these results indicate that scFvs combined with chemotherapy can effectively inhibit tumor metastasis and progression.
| DISCUSSION
Previous researchers have reported that cancer stem-like microsphere cells can be enriched from their parental cells, 26, 27 and microspheres contain a higher proportion of stem cells to proliferate and invade in some collective ways. 4, 28 Most interestingly, it has been observed that CSCs or cell clusters leave traces in the circulatory system during their process of metastasis. 6, 28 We infer that these traces of metastasis might be identified and remembered by the early antibody immune response. However, these antibody levels are extremely low, far less than direct tumor immune antibody stimulation, nor do they effectively stimulate an immune treatment response. However, these antibodies can be enriched and modified as antitumor antibody libraries, such as the development of CSC-targeted chimeric antigen receptor T cells. 29 In this study, we developed scFv libraries that were sourced from breast cancer patients' peripheral blood lymphocytes and increased the storage capacity of these libraries through mutation and recombination by splicing by overlap extension PCR technology. 30 These libraries included the . Data are expressed as the mean AE SEM and compared by t-test. *P < .05; **P < .01; ***P < .001 natural immune information, which might reflect the current disease state of the patients (Table S1 ). For instance, we found a higher Leu/Lym rate from cancer patients could build more stable libraries (Table S1) . 31, 32 Our results suggested that there was a positive relationship between the degree of immunity and the antibody library.
Our data showed that the construction of scFv libraries from peripheral blood in early stage cancer was also reliable, and it might not be related to the stage and type of tumors.
Screening antibody molecules that take into account stem-like cells and cancer cells should be one of the directions for future research on immunity. 20, 26 Thus, our screening methods were not only based on the affinity to the microspheres but also dependent on the selective effect on their early differentiated cells. 4, 19, 28 This approach ensured that subsequent identification and treatment was effective both for the microspheres and cancer cells (Figure 3 ). The solid platform display technology has been shown to be mature in vitro. 33, 34 In this study, we used the microspheres as a screening platform, which kept the cell membrane surface antigens complete and similar to their natural characteristics. Through the direct screening of antibodies without prior experience in intact cells, some unknown and affinity ligands were found ( Figure 4D-F) . This showed that we obtained highaffinity scFvs that combined with microspheres by repeated panning, which showed high affinity to CD44 and CD24 ( Figure 5E , F). Our results showed that the scFvs changed in vitro to identify a variety of different antigens ( Figure 5D ,E), following Darwin's evolutionary theory. 11, 14, 35 Ribosome display technology can select even nanomolar concentrations of a DNA template library. 10 Through the amplification of PCR, the trace mRNA can be released and detected from the mRNA-peptide affinity of the ribosome complex. These new mRNAs can be used for the next round of screening, and they can also be amplified, sequenced, and cloned into vectors. 35, 36 In this study, we showed the screening molecular banding and we repeatedly purified, sequenced, and amplified the target products ( Figure S2 ). Previous research has shown that PCR is also a convenient mutagenesis strategy 37 ; therefore, the results of iterations between diversification and selection allow for protein evolution in vitro by RD. 36, 38 We showed that proteins were expressed from the ribosome complex in in vitro translation ( Figure 4D-F) . At the beginning, the target band was weak, but several high-molecular-weight proteins were expressed ( Figure 4E ). The target proteins could be enhanced and enriched in multiple rounds of screening. We showed that the translated proteins had some antitumor activity because they were located in a similar position to the serum protein that was isolated from the breast cancer patient, whereas both the breast cancer and HBL-100 cells lacked the biotinylated proteins ( Figure 4D-F) . Therefore, the successful implementation of RD allowed us to obtain the evolved scFvs, which can synthesize high-affinity proteins against targets (Figures 4 and S2d) .
Single-chain variable fragments (scFv) and combination treatment inhibited tumor invasion and progression. A, Microspheres control group and treatment group cells were treated for 24 hours in the upper chamber of 24-well Transwell plates, and the collective migrating and invading cells were representatively imaged (9200) and quantitatively analyzed. Data are expressed as the mean AE SD and compared by one-way ANOVA. B, Analysis of tumor volume and a growth curve of five mice in each group injected with microspheres. The treatment group was injected with the adjacent tumor followed with 100 nmol/L scFv and 4 lg/mL epirubicin (30 lL) at approximately 10 days. The control group was injected with 60 lL PBS. C, Morphologies of liver, heart, lung, and spleen in the two groups. Liver metastasis was only present in the PBS control group (white and blue arrows). D, Morphologies and toxic reaction of the liver, lung, and spleen in both groups by H&E staining (9200). E, Representative photographs of immunohistochemistry analysis using anti-PCNA, anti-MMP9, and anti-CD44 staining in both groups (9200). F, Western blot analysis of CD44 and CD24 in the two groups. G, Western blot analysis of ERK, p38, and JNK. Data are expressed as the mean AE SEM and compared by t-test. *P < .05; **P < .01; ***P < .001
Chimeric antigen receptor T cell technology is an important technology with rapid development in recent years. 39, 40 However, its application in the treatment of solid tumors is relatively limited, and the function of scFvs has not been completely discussed. 41 In this study, we showed that selected scFvs significantly inhibited the proliferation and invasion of microspheres at a certain concentration ( Figure 5A ). Interestingly, the high-affinity targets might be CD44 + / CD24 + . As CD44 + CD24 À and CD44 + CD24 + were both highly expressed in the microspheres and MDA-MB-231 cells ( Figure 3A) , we believed that our selected scFvs could inhibit the related effects of stemness, proliferation, and differentiation at the same time, which could cause a chain reaction. 42, 43 It was shown that the combination treatment significantly reduced the MAPK pathway proteins' expression, and we considered the MAPK pathway to be C and 6A ). However, the apoptosis effect of microspheres was significantly promoted when the combination treatment was used. In another way, this synergistic effect of molecular combination chemotherapy is similar to the research into aptamers. 25, 44, 45 Taking scFvs as aptamers, they will be more beneficial to clinical treatment, as they are much more capable of mass synthesis, further editing, and modification ( Figure S2 ). In addition, the scFvs have been considered for wide use against many kinds of tumors. 46 Thus, the screening scFvs might be another effective immune and molecular therapy method, as they have a synergistic effect on clusters of microspheres and cancer cells. We consider that this synergistic effect might be due to high-affinity precise binding and then inhibition of the shared stemness and proliferation signaling pathways in CSCs and cancer cells.
In summary, this study showed that scFvs from dynamic screening by RD in a natural state could result in high-affinity evolution to recognize microspheres. The scFvs could effectively inhibit the collective growth and invasion of microspheres through targets that might be CD44 + /CD24 + . When combined with chemotherapy, the scFvs showed enhancement of their high-affinity efficiency in inhibiting the proliferation and invasion of microspheres in vitro and in vivo.
ACKNOWLEDGMENTS
This work was supported by grants from the National Natural Science Foundation of China (No. 81272898). We sincerely thank
Professor Wei Duan (Deakin University, Australia) for fruitful discussions.
CONF LICT OF I NTEREST
The authors have no conflict of interest.
O R C I D Shangke Huang http://orcid.org/0000-0002-9356-7588
